{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:09:34Z","timestamp":1788797374275,"version":"build-2803163510"},"reference-count":88,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017236","name":"Huffington Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017236","id-type":"DOI","asserted-by":"publisher"}]},{"name":"McGee Family Foundation"},{"name":"Silverstein Foundation"},{"name":"Houston Methodist Foundation"},{"name":"Jan and Dan Duncan Neurological Research Institute"},{"DOI":"10.13039\/100007137","name":"Texas Children\u2019s Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007137","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Effie Marie Caine Endowed Chair for Alzheimer\u2019s Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The molecular pathways linking genetic variants to Parkinson\u2019s disease (PD) onset and progression remain incompletely defined; however, risk alleles in multiple genes, including GBA1, strongly implicate lipid metabolism.<\/jats:p>\n                  <jats:p>To systematically identify causal biomarker signatures, we analysed comprehensive metabolome profiles from blood plasma in 149 PD patients and 150 controls, along with complementary genetic, RNA-sequencing and metabolic data from other available clinical and pathologic cohorts. Using colocalization and summary-data-based Mendelian randomization, we tested whether expression and metabolic quantitative trait loci mediate the association between implicated genetic variants and PD risk. We further integrated differential metabolomics and proteomics from blood and brain to reveal pertinent mechanisms.<\/jats:p>\n                  <jats:p>We show that common PD risk variants at the serine palmitoyltransferase small subunit B (SPTSSB) locus, a key regulator of de novo sphingolipid biosynthesis, are associated with increased SPTSSB brain expression and elevated plasma ceramides. Additional analyses strongly support our hypothesis that a common SPTSSB causal variant is responsible for PD risk as well as the expression and metabolic quantitative trait loci. Multiple sphingolipids and fatty acid derivatives were perturbed in PD, and we identified both unique and shared features with the Alzheimer\u2019s disease metabolome. A PD acylcarnitine signature was further replicated in human post-mortem brain tissue, when comparing those with or without preclinical Lewy body pathology. Integrated analysis of complementary brain proteomic profiles revealed dysregulation of mitochondrial processes dependent on acylcarnitines, including fatty acid beta-oxidation, the tricarboxylic acid cycle and oxidative phosphorylation.<\/jats:p>\n                  <jats:p>Our results identify promising biomarkers and reveal a causal chain linking genetic variation to altered gene\/protein expression, lipid dysmetabolism, and the manifestation of PD.<\/jats:p>","DOI":"10.1093\/brain\/awag039","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:46:02Z","timestamp":1769777162000},"page":"3119-3133","source":"Crossref","is-referenced-by-count":3,"title":["Mapping the causal chain from genetic risk variants to lipid dysmetabolism in Parkinson\u2019s disease"],"prefix":"10.1093","volume":"149","author":[{"given":"Ruth B","family":"De-Paula","sequence":"first","affiliation":[{"name":"Quantitative and Computational Biosciences Program, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonggeol","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Rhinn","sequence":"additional","affiliation":[{"name":"Leal Therapeutics , Worcester, MA 01605 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Saade","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Chavez","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e9ah","family":"Segura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Valeria","family":"Lozano","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Etoundi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Silos","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kass","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Korchina","sequence":"additional","affiliation":[{"name":"Human Genome Sequencing Center, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshavardhan","family":"Doddapaneni","sequence":"additional","affiliation":[{"name":"Human Genome Sequencing Center, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Venner","sequence":"additional","affiliation":[{"name":"Human Genome Sequencing Center, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9955-6954","authenticated-orcid":false,"given":"Joseph C","family":"Masdeu","sequence":"additional","affiliation":[{"name":"Nantz National Alzheimer Center, Houston Methodist Neurological Institute and Weill Cornell Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valory","family":"Pavlik","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ying R","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-2742","authenticated-orcid":false,"given":"Aron S","family":"Buchman","sequence":"additional","affiliation":[{"name":"Rush Alzheimer's Disease Center, Rush University Medical Center , Chicago, IL 60612 ,","place":["USA"]},{"name":"Department of Neurological Sciences, Rush University Medical Center , Chicago, IL 60612 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Muzny","sequence":"additional","affiliation":[{"name":"Human Genome Sequencing Center, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Gibbs","sequence":"additional","affiliation":[{"name":"Human Genome Sequencing Center, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1400-8519","authenticated-orcid":false,"given":"Sarah H","family":"Elsea","sequence":"additional","affiliation":[{"name":"Human Genome Sequencing Center, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa","family":"Abeliovich","sequence":"additional","affiliation":[{"name":"Leal Therapeutics , Worcester, MA 01605 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lansbury","sequence":"additional","affiliation":[{"name":"Department of Neurology, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Vanegas-Arroyave","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]},{"name":"Center for Alzheimer\u2019s and Neurodegenerative Diseases, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad A","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]},{"name":"Center for Alzheimer\u2019s and Neurodegenerative Diseases, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]},{"name":"Jan and Dan Duncan Neurological Research Institute, Texas Children\u2019s Hospital , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1835-1971","authenticated-orcid":false,"given":"Joshua M","family":"Shulman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]},{"name":"Center for Alzheimer\u2019s and Neurodegenerative Diseases, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]},{"name":"Jan and Dan Duncan Neurological Research Institute, Texas Children\u2019s Hospital , Houston, TX 77030 ,","place":["USA"]},{"name":"Department of Neuroscience, Baylor College of Medicine , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2026090711271968600_awag039-B1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson\u2019s syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"2026090711271968600_awag039-B2","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"2026090711271968600_awag039-B3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"2026090711271968600_awag039-B4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher\u2019s disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem Biophys Res Commun"},{"key":"2026090711271968600_awag039-B5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: A meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol"},{"key":"2026090711271968600_awag039-B6","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/brain\/awac413","article-title":"GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson\u2019s disease","volume":"146","author":"Senkevich","year":"2023","journal-title":"Brain"},{"key":"2026090711271968600_awag039-B7","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/mds.29521","article-title":"Association of rare variants in ARSA with Parkinson\u2019s disease","volume":"38","author":"Senkevich","year":"2023","journal-title":"Mov Disord."},{"key":"2026090711271968600_awag039-B8","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1093\/brain\/awz205","article-title":"Arylsulfatase A, a genetic modifier of Parkinson\u2019s disease, is an \u03b1-synuclein chaperone","volume":"142","author":"Lee","year":"2019","journal-title":"Brain"},{"key":"2026090711271968600_awag039-B9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/mds.27642","article-title":"SMPD1 mutations, activity, and \u03b1-synuclein accumulation in Parkinson\u2019s disease","volume":"34","author":"Alcalay","year":"2019","journal-title":"Mov Disord."},{"key":"2026090711271968600_awag039-B10","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1038\/s41467-022-30875-7","article-title":"Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease","volume":"13","author":"Cadby","year":"2022","journal-title":"Nat Commun"},{"key":"2026090711271968600_awag039-B11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"2026090711271968600_awag039-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: Mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat Med"},{"key":"2026090711271968600_awag039-B13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"2026090711271968600_awag039-B14","doi-asserted-by":"crossref","first-page":"168000","DOI":"10.1016\/j.jmb.2023.168000","article-title":"Role of ceramides and sphingolipids in Parkinson\u2019s disease","volume":"435","author":"Vos","year":"2023","journal-title":"J Mol Biol"},{"key":"2026090711271968600_awag039-B15","doi-asserted-by":"crossref","first-page":"1137893","DOI":"10.3389\/fnins.2023.1137893","article-title":"Sphingolipids in neurodegenerative diseases","volume":"17","author":"Pan","year":"2023","journal-title":"Front Neurosci"},{"key":"2026090711271968600_awag039-B16","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson\u2019s disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Mov Disord."},{"key":"2026090711271968600_awag039-B17","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1093\/brain\/awac176","article-title":"Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease","volume":"145","author":"Galper","year":"2022","journal-title":"Brain"},{"key":"2026090711271968600_awag039-B18","doi-asserted-by":"crossref","first-page":"E848","DOI":"10.1212\/WNL.0000000000013225","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"key":"2026090711271968600_awag039-B19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41531-021-00241-3","article-title":"Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson\u2019s disease enrolled in PPMI","volume":"7","author":"Huh","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"2026090711271968600_awag039-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-022-00363-2","article-title":"Elevation of gangliosides in four brain regions from Parkinson\u2019s disease patients with a GBA mutation","volume":"8","author":"Blumenreich","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"2026090711271968600_awag039-B21","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.29163","article-title":"Glycosphingolipid changes in plasma in Parkinson\u2019s disease independent of glucosylceramide levels","volume":"37","author":"te Vruchte","year":"2022","journal-title":"Mov Disord"},{"key":"2026090711271968600_awag039-B22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.29360","article-title":"A biomarker study in patients with GBA1-Parkinson\u2019s disease and healthy controls","volume":"38","author":"den Heijer","year":"2023","journal-title":"Mov Disord."},{"key":"2026090711271968600_awag039-B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-024-00732-z","article-title":"Identification of metabolites reproducibly associated with Parkinson\u2019s disease via meta-analysis and computational modelling","volume":"10","author":"Luo","year":"2024","journal-title":"NPJ Parkinsons Disease"},{"key":"2026090711271968600_awag039-B24","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awv179","article-title":"Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations","volume":"138","author":"Alcalay","year":"2015","journal-title":"Brain"},{"key":"2026090711271968600_awag039-B25","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","article-title":"The role of PINK1\u2013Parkin in mitochondrial quality control","volume":"26","author":"Narendra","year":"2024","journal-title":"Nat Cell Biol"},{"key":"2026090711271968600_awag039-B26","doi-asserted-by":"crossref","first-page":"a040576","DOI":"10.1101\/cshperspect.a040576","article-title":"Lipid metabolism","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026090711271968600_awag039-B27","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1038\/s41588-024-01973-7","article-title":"Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traits","volume":"56","author":"Wang","year":"2024","journal-title":"Nat Genet"},{"key":"2026090711271968600_awag039-B28","doi-asserted-by":"crossref","first-page":"E1821","DOI":"10.1212\/WNL.0000000000007315","article-title":"Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies","volume":"92","author":"Buchman","year":"2019","journal-title":"Neurology"},{"key":"2026090711271968600_awag039-B29","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/alz.12714","article-title":"The landscape of metabolic brain alterations in Alzheimer\u2019s disease","volume":"19","author":"Batra","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"s1","key":"2026090711271968600_awag039-B30","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.3233\/JAD-179939","article-title":"Religious orders study and rush memory and aging project","volume":"64","author":"Bennett","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2026090711271968600_awag039-B31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.WNL.0000152982.47274.9E","article-title":"Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions","volume":"64","author":"Bennett","year":"2005","journal-title":"Neurology"},{"key":"2026090711271968600_awag039-B32","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"2026090711271968600_awag039-B33","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005072-199710000-00002","article-title":"Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease","volume":"56","author":"Hyman","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026090711271968600_awag039-B34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41586-024-07606-7","article-title":"Single-cell multiregion dissection of Alzheimer\u2019s disease","volume":"632","author":"Mathys","year":"2024","journal-title":"Nature"},{"key":"2026090711271968600_awag039-B35","doi-asserted-by":"crossref","first-page":"e200002","DOI":"10.1212\/NXG.0000000000200002","article-title":"Genome sequencing in the Parkinson disease clinic","volume":"8","author":"Hill","year":"2022","journal-title":"Neurol Genet"},{"key":"2026090711271968600_awag039-B36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1101\/gr.213611.116","article-title":"Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly","volume":"27","author":"Schneider","year":"2017","journal-title":"Genome Res"},{"key":"2026090711271968600_awag039-B37","first-page":"1","article-title":"Comprehensive genome analysis and variant detection at scale using DRAGEN","volume":"25","author":"Behera","year":"2024","journal-title":"Nat Biotechnol"},{"key":"2026090711271968600_awag039-B38","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1212\/NXG.0000000000000104","article-title":"GBA P.T369M substitution in Parkinson disease: Polymorphism or association? A meta-analysis","volume":"2","author":"Mallett","year":"2016","journal-title":"Neurol Genet"},{"key":"2026090711271968600_awag039-B39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ymgme.2019.10.001","article-title":"Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson\u2019s disease risk?","volume":"128","author":"Goldstein","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"W1","key":"2026090711271968600_awag039-B40","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026090711271968600_awag039-B41","author":"R Core Team"},{"key":"2026090711271968600_awag039-B42","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"Ggplot2: Elegant graphics for data analysis","author":"Wickham","year":"2016"},{"key":"2026090711271968600_awag039-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i07","article-title":"Multivariate and propensity score matching software with automated balance optimization: The matching package for R","volume":"42","author":"Sekhon","year":"2011","journal-title":"J Stat Softw"},{"key":"2026090711271968600_awag039-B44","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1038\/s41591-022-02046-0","article-title":"Rare and common genetic determinants of metabolic individuality and their effects on human health","volume":"28","author":"Surendran","year":"2022","journal-title":"Nat Med."},{"key":"2026090711271968600_awag039-B45","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"key":"2026090711271968600_awag039-B46","author":"GALC\/coloc at main"},{"key":"2026090711271968600_awag039-B47","doi-asserted-by":"publisher","author":"(GP2) TGPGP","DOI":"10.1101\/2025.03.14.24319455"},{"key":"2026090711271968600_awag039-B48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nat Genet."},{"key":"2026090711271968600_awag039-B49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet."},{"key":"2026090711271968600_awag039-B50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","article-title":"Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level","volume":"25","author":"Johnson","year":"2022","journal-title":"Nat Neurosci."},{"key":"2026090711271968600_awag039-B51","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"2026090711271968600_awag039-B52","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/1873-3468.14457","article-title":"The sphingolipid anteome: Implications for evolution of the sphingolipid metabolic pathway","volume":"596","author":"Santos","year":"2022","journal-title":"FEBS Lett"},{"key":"2026090711271968600_awag039-B53","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/brain\/awac460","article-title":"SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia","volume":"146","author":"Srivastava","year":"2023","journal-title":"Brain"},{"key":"2026090711271968600_awag039-B54","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/acn3.52013","article-title":"SPTLC2 variants are associated with early-onset ALS and FTD due to aberrant sphingolipid synthesis","volume":"11","author":"Naruse","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"2026090711271968600_awag039-B55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/jnnp-2023-332130","article-title":"Recurrent de-novo gain-of-function mutation in SPTLC2 confirms dysregulated sphingolipid production to cause juvenile amyotrophic lateral sclerosis","volume":"95","author":"Dohrn","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026090711271968600_awag039-B56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jnnp-2023-332132","article-title":"Recurrent de novo SPTLC2 variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesis","volume":"95","author":"Syeda","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026090711271968600_awag039-B57","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41593-022-01128-z","article-title":"Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders","volume":"25","author":"Bryois","year":"2022","journal-title":"Nat Neurosci"},{"key":"2026090711271968600_awag039-B58","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/nn.4632","article-title":"An xQTL map integrates the genetic architecture of the human brain\u2019s transcriptome and epigenome","volume":"20","author":"Ng","year":"2017","journal-title":"Nat Neurosci"},{"key":"2026090711271968600_awag039-B59","first-page":"1","article-title":"Prioritizing Parkinson\u2019s disease genes using population-scale transcriptomic data","volume":"10","author":"Li","year":"2019","journal-title":"Nat Commun."},{"key":"2026090711271968600_awag039-B60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00425-8","article-title":"Comprehensive metabolic profiling of Parkinson\u2019s disease by liquid chromatography-mass spectrometry","volume":"16","author":"Shao","year":"2021","journal-title":"Mol Neurodegener"},{"key":"2026090711271968600_awag039-B61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06767-y","article-title":"Decreased long-chain acylcarnitines from insufficient \u03b2-oxidation as potential early diagnostic markers for Parkinson\u2019s disease","volume":"7","author":"Saiki","year":"2017","journal-title":"Sci Rep"},{"key":"2026090711271968600_awag039-B62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.mam.2004.06.006","article-title":"Carnitine: A nutritional, biosynthetic, and functional perspective","volume":"25","author":"Steiber","year":"2004","journal-title":"Mol Aspects Med"},{"key":"2026090711271968600_awag039-B63","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jalz.2017.01.008","article-title":"Dysregulation of lipids in Alzheimer\u2019s disease and their role as potential biomarkers","volume":"13","author":"Wong","year":"2017","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2026090711271968600_awag039-B64","doi-asserted-by":"crossref","first-page":"e1002482","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med"},{"key":"2026090711271968600_awag039-B65","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/alz.12468","article-title":"Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer\u2019s disease","volume":"18","author":"Horgusluoglu","year":"2022","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2026090711271968600_awag039-B66","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.22588","article-title":"Nigral pathology and parkinsonian signs in elders without Parkinson disease","volume":"71","author":"Buchman","year":"2012","journal-title":"Ann Neurol"},{"key":"2026090711271968600_awag039-B67","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pediatrneurol.2017.06.014","article-title":"Clinical metabolomics to segregate aromatic amino acid decarboxylase deficiency from drug-induced metabolite elevations","volume":"75","author":"Pappan","year":"2017","journal-title":"Pediatr Neurol"},{"key":"2026090711271968600_awag039-B68","doi-asserted-by":"crossref","first-page":"1310094","DOI":"10.3389\/fimmu.2023.1310094","article-title":"The role of midkine in health and disease","volume":"14","author":"Neumaier","year":"2023","journal-title":"Front Immunol"},{"key":"2026090711271968600_awag039-B69","doi-asserted-by":"crossref","first-page":"101669","DOI":"10.1016\/j.xcrm.2024.101669","article-title":"Integrative proteomics identifies a conserved A\u03b2 amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer\u2019s disease","volume":"5","author":"Levites","year":"2024","journal-title":"Cell Rep Med"},{"key":"2026090711271968600_awag039-B70","first-page":"1","article-title":"Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer\u2019s disease","volume":"19","author":"Shantaraman","year":"2024","journal-title":"Mol Neurodegener"},{"key":"2026090711271968600_awag039-B71","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1073\/pnas.0811269106","article-title":"Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities","volume":"106","author":"Han","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090711271968600_awag039-B72","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00424-024-03018-8","article-title":"Atypical sphingosine-1-phosphate metabolites\u2014Biological implications of alkyl chain length","volume":"476","author":"Glueck","year":"2024","journal-title":"Pflugers Arch"},{"key":"2026090711271968600_awag039-B73","doi-asserted-by":"crossref","first-page":"12962","DOI":"10.1073\/pnas.1516733112","article-title":"Elevation of 20-carbon long chain bases due to a mutation in serine palmitoyltransferase small subunit b results in neurodegeneration","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090711271968600_awag039-B74","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbalip.2018.12.013","article-title":"1-Deoxysphingolipids","volume":"1864","author":"Lone","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2026090711271968600_awag039-B75","author":"The Human Protein Atlas"},{"key":"2026090711271968600_awag039-B76","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"Aguet","year":"2020","journal-title":"Science"},{"key":"2026090711271968600_awag039-B77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/jcbfm.2012.151","article-title":"Heptanoate as a neural fuel: Energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain","volume":"33","author":"Marin-Valencia","year":"2013","journal-title":"J Cereb Blood Flow Metab."},{"key":"2026090711271968600_awag039-B78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-nutr-120420-025558","article-title":"Ins and outs of the TCA cycle: The central role of anaplerosis","volume":"41","author":"Inigo","year":"2021","journal-title":"Annu Rev Nutr"},{"key":"2026090711271968600_awag039-B79","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10545-017-0085-8","article-title":"Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: A double blinded, randomized controlled trial","volume":"40","author":"Gillingham","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"2026090711271968600_awag039-B80","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jnr.24111","article-title":"Triheptanoin for the treatment of brain energy deficit: A 14-year experience","volume":"95","author":"Mochel","year":"2017","journal-title":"J Neurosci Res"},{"key":"2026090711271968600_awag039-B81","doi-asserted-by":"crossref","first-page":"e210194","DOI":"10.1212\/WNL.0000000000210194","article-title":"Effect of triheptanoin on caudate atrophy and motor scores in patients with early-stage Huntington disease: A phase II study","volume":"104","author":"Mochel","year":"2025","journal-title":"Neurology"},{"key":"2026090711271968600_awag039-B82","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/epi.17263","article-title":"A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndrome","volume":"63","author":"Striano","year":"2022","journal-title":"Epilepsia"},{"key":"2026090711271968600_awag039-B83","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: From mechanism to therapy","volume":"46","author":"Malpartida","year":"2021","journal-title":"Trends Biochem Sci"},{"key":"2026090711271968600_awag039-B84","doi-asserted-by":"crossref","first-page":"eaba1193","DOI":"10.1126\/sciadv.aba1193","article-title":"Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological \u03b1-synuclein","volume":"6","author":"Chung","year":"2020","journal-title":"Sci Adv"},{"key":"2026090711271968600_awag039-B85","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ncl.2020.08.003","article-title":"Toxin-induced Parkinsonism","volume":"38","author":"McKnight","year":"2020","journal-title":"Neurol Clin"},{"key":"2026090711271968600_awag039-B86","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1016\/j.celrep.2018.03.017","article-title":"Serine availability influences mitochondrial dynamics and function through lipid metabolism","volume":"22","author":"Gao","year":"2018","journal-title":"Cell Rep"},{"key":"2026090711271968600_awag039-B87","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41582-025-01142-2","article-title":"Parkinson disease is a fatty acidopathy","volume":"21","author":"Fanning","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"2026090711271968600_awag039-B88","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41593-022-01031-7","article-title":"Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain","volume":"25","author":"Vialle","year":"2022","journal-title":"Nat Neurosci"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awag039\/66709313\/awag039.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/149\/9\/3119\/66709313\/awag039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/149\/9\/3119\/66709313\/awag039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:27:41Z","timestamp":1788794861000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/149\/9\/3119\/8455019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":88,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,2,2]]},"published-print":{"date-parts":[[2026,9,7]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awag039","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,2,2]]}}}